Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose Finding Study Assessing Safety and Tolerability of SST0001 in Advanced Multiple Myeloma.

NCT01764880 is registered in ClinicalTrials.gov with Sigma Tau Research Switzerland SA as lead sponsor.

NCT NCT01764880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose Finding Study Assessing Safety and Tolerability of SST0001 in Advanced Multiple Myeloma.
Lead sponsor
Sigma Tau Research Switzerland SA
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
November 30, 2016
Enrollment
19 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma